Gabriel, Erin E <br/><br/>
Evaluating principal surrogate endpoints with time-to-event data accounting for time-varying treatment efficacy.  [electronic resource] 

 -  Biostatistics (Oxford, England)  Apr 2014 
 - 251-65 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1468-4357 
<br/><br/><label>Standard No.: </label>10.1093/biostatistics/kxt055  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Biomarkers<br/>Diabetes Complications--prevention & control<br/>Diabetes Mellitus, Type 1--drug therapy<br/>Endpoint Determination<br/>Humans<br/>Likelihood Functions<br/>Models, Statistical<br/>Randomized Controlled Trials as Topic--standards<br/>Research Design--standards<br/>Risk Assessment<br/>Time Factors<br/>Treatment Outcome